WATSON 461 (Glipizide 10 mg)
Pill imprint WATSON 461 has been identified as Glipizide 10 mg.
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 461 (Glipizide 10 mg)
- 10 mg
- 10.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
|NDC Code||Manufacturer / Repackager|
|63739-0117||McKesson Packaging Services|
|54569-3842||A S Medication Solutions LLC (repackager)|
|67544-0129||Prepak Systems Inc (repackager)|
|16590-0287||Stat RX USA LLC (repackager)|
|68258-1013||Dispensing Solutions Inc. (repackager)|
|66336-0662||Dispensing Solutions Inc. (repackager)|
|58016-0376||Southwood Pharmaceuticals Inc (repackager)|
|63874-0432||Altura Pharmaceuticals Inc (repackager)|
|54868-3319||Physicians Total Care Inc (repackager)|
|21695-0470||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.